Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.71
-0.16 (-2.33%)
At close: Oct 13, 2026, 4:00 PM EDT
6.80
+0.09 (1.34%)
After-hours: Oct 13, 2026, 7:56 PM EDT

Gyre Therapeutics Revenue

Gyre Therapeutics had revenue of $29.11M in the quarter ending June 30, 2026, a decrease of -2.12%. This brings the company's revenue in the last twelve months to $119.38M, up 13.53% year-over-year. In the year 2025, Gyre Therapeutics had annual revenue of $116.59M with 10.24% growth. That makes Gyre Therapeutics the 21,895th largest company in the world by revenue and 3,230th in the United States.

Revenue (ttm)
$119.38M
Revenue Growth
+13.53%
P/S Ratio
6.48
Revenue / Employee
$175,709
Employees
625
Market Cap
711.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025116.59M10.83M10.24%
Dec 31, 2024105.76M-7.69M-6.78%
Dec 31, 2023113.45M11.16M10.91%
Dec 31, 2022102.29M94.95M1,293.98%
Dec 31, 20217.34M-34.56M-82.49%
Dec 31, 202041.90M--
Dec 31, 2019---
Dec 31, 20186.00K-1.01M-99.41%
Dec 31, 20171.02M619.00K155.14%
Dec 31, 2016399.00K-1.35M-77.20%
Dec 31, 20151.75M-63.00K-3.47%
Dec 31, 20141.81M1.29M246.65%
Dec 31, 2013523.00K-115.20M-99.55%
Dec 31, 2012115.72M-79.55M-40.74%
Dec 31, 2011195.27M23.85M13.91%
Dec 31, 2010171.43M121.30M242.00%
Dec 31, 200950.12M9.95M24.78%
Dec 31, 200840.17M17.02M73.51%
Dec 31, 200723.15M-31.92M-57.96%
Dec 31, 200655.07M52.71M2,233.81%
Dec 31, 20052.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MiMedx Group355.17M
Apnimed115.12M
4D Molecular Therapeutics92.01M
Lexicon Pharmaceuticals41.47M
OmniAb38.46M
Revenue Rankings